NEW YORK, July 6, 2017 /PRNewswire/ --
Elsevier, the information analytics company specializing in science
Launched in 2010, the Reaxys PhD Prize celebrates chemistry PhD students and recent graduates, fostering creativity in ground-breaking chemistry. Besides identifying tomorrow's chemistry leaders, the Prize seeks to empower them to magnify the impact of their work. This starts with the Prize Symposium, where the finalists are provided with an international stage for presenting their research and the opportunity to extend their network with their fellow finalists and internationally recognized chemists.
The 2017 Reaxys PhD Prize Symposium is also the occasion for the Reaxys Advisory Board and Prize coordinators to select the three winners, based on the originality, innovation, relevance and methodological rigor of their presented work. The winners will be announced at the banquet following the Symposium.
The selection of the winners is the last step of a long and rigorous review process. Started in March, the process involved more than 100 international chemists from academia and industry, who, together with Prize Coordinators, are the key to ensure a fair and rigorous selection process.
"As one of the Prize coordinators since 2010, I am very proud to see the continued developed of the Prize. The quality of the submissions is fantastic," said Prof Henry N. C. Wong of the Chinese University of Hong Kong. "I know we will have another difficult but exciting discussion in order to identify this year's winners. I am looking forward to the Symposium in Shanghai and to meeting the finalists in person. Their enthusiasm for their research and for chemistry is one of the most rewarding aspects of the meeting."
This year's 45 finalists are:
Find out more about the Reaxys PhD Prize and Symposium.
Reaxys is a trademark of RELX Intellectual Properties SA, used under license. About Elsevier
Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. http://www.elsevier.com
Media contact Christopher Capot Global Communications, Elsevier +1-917-704-5174 email@example.com
Subscribe to our Free Newsletters!
Bronchopulmonary dysplasia or chronic lung disease of infancy is seen in premature and low birth ...
Ear, nose and throat are important organs and disease in one area can affect the others. ENT ...
If you want to stop breastfeeding, then here is your guide to doing it the right way. Find the ...View All